343 related articles for article (PubMed ID: 4865460)
1. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
Danieli G
G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460
[No Abstract] [Full Text] [Related]
2. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
[No Abstract] [Full Text] [Related]
3. [Methylhydrazine in the therapy of malignant lymphopathies].
Beltrametti L; Almici C
Policlinico Prat; 1967 Jan; 74(3):82-5. PubMed ID: 4878309
[No Abstract] [Full Text] [Related]
4. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
Böhnel J; Stacher A
Wien Med Wochenschr; 1966 May; 116(21):468-71. PubMed ID: 4863533
[No Abstract] [Full Text] [Related]
5. [Ambulatory endoxan therapy by high doses].
Fischer M; Martin H; Schubert JC
Dtsch Med Wochenschr; 1967 Jun; 92(25):1145-50. PubMed ID: 5338225
[No Abstract] [Full Text] [Related]
6. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
Havemann K; Schmidt M; Malchow H; Sodomann CP
Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
[No Abstract] [Full Text] [Related]
7. Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.
Cridland MD
Drugs; 1972; 3(5):331-51. PubMed ID: 4347084
[No Abstract] [Full Text] [Related]
8. [New viewpoints for indication for radiologic treatment in leukoses and retikuloses].
Musshoff K
Strahlentherapie; 1968 Jun; 135(6):641-55. PubMed ID: 4878792
[No Abstract] [Full Text] [Related]
9. [Results of cytostatic therapy of malignant hemoblastoses].
Stacher A
Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311
[No Abstract] [Full Text] [Related]
10. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
Cajozzo A; Citarrella P; Carreca I; D'Eredità F
Haematologica; 1970; 55(7):465-70. PubMed ID: 4996520
[No Abstract] [Full Text] [Related]
11. [Cytostatic therapy of hemoblastosis].
Ehrhart H
Pharmakotherapia; 1964; 2(1):59-88. PubMed ID: 5337120
[No Abstract] [Full Text] [Related]
12. [Therapeutic progress and iatrogenic problems in malignant hemopathies].
Geib KR; Papazian R
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(4):343-9. PubMed ID: 22916
[No Abstract] [Full Text] [Related]
13. [Current therapy of malignant blood diseases].
de Werra P
Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
[No Abstract] [Full Text] [Related]
14. Chemotherapy of the lymphomas.
Lacher MJ
Med Times; 1970 May; 98(5):96-102. PubMed ID: 4911076
[No Abstract] [Full Text] [Related]
15. [Life expectancy of hemoblastosis patients].
Obrecht P
Med Klin; 1966 Dec; 61(50):1985-90. PubMed ID: 5239386
[No Abstract] [Full Text] [Related]
16. [Current status of cytostatic therapy].
Wilmanns W
Wien Med Wochenschr; 1974 Nov; 124(48):699-707. PubMed ID: 4611049
[No Abstract] [Full Text] [Related]
17. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
Hansen MM; Hertz H; Videaek A
Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
[No Abstract] [Full Text] [Related]
18. The comparative value of several tests in predicting the response to chemotherapy in patients with malignant hemophathies.
Cheţa D; Micu D; Cheţa N
Med Interne; 1979; 17(4):353-7. PubMed ID: 390678
[No Abstract] [Full Text] [Related]
19. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)].
Arroyo de la Fuente F; Lasheras Garde J; Triginer Boixeda J
Sangre (Barc); 1966; 11(3):265-70. PubMed ID: 6012465
[No Abstract] [Full Text] [Related]
20. [Corticosteroids in oncology].
Cleton FJ
Ned Tijdschr Geneeskd; 1977 Oct; 121(43):1715-20. PubMed ID: 270013
[No Abstract] [Full Text] [Related]
[Next] [New Search]
